Total Payments
$9,299
2024 Payments
$1,673
Companies
7
Transactions
94
Payment Breakdown by Category
Travel$3,706 (39.9%)
Consulting$2,100 (22.6%)
Research$1,783 (19.2%)
Food & Beverage$1,710 (18.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $3,706 | 37 | 39.9% |
| Consulting Fee | $2,100 | 2 | 22.6% |
| Unspecified | $1,783 | 18 | 19.2% |
| Food and Beverage | $1,710 | 37 | 18.4% |
Payments by Type
General
$7,516
76 transactions
Research
$1,783
18 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nevro Corp. | $3,622 | 11 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $1,673 | 17 | $0 (2024) |
| Mitsubishi Tanabe Pharma Development America, Inc. | $1,626 | 13 | $0 (2017) |
| Eli Lilly and Company | $1,341 | 33 | $0 (2023) |
| Ichnos Sciences Inc. | $907.37 | 12 | $0 (2020) |
| ABBVIE INC. | $115.59 | 7 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $13.62 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,673 | 17 | E.R. Squibb & Sons, L.L.C. ($1,673) |
| 2023 | $98.80 | 1 | Eli Lilly and Company ($98.80) |
| 2022 | $136.76 | 4 | Eli Lilly and Company ($85.00) |
| 2021 | $2,406 | 7 | Nevro Corp. ($2,100) |
| 2020 | $1,337 | 14 | Ichnos Sciences Inc. ($907.37) |
| 2019 | $485.12 | 28 | Eli Lilly and Company ($485.12) |
| 2018 | $1,522 | 9 | Nevro Corp. ($1,522) |
| 2017 | $1,640 | 14 | Mitsubishi Tanabe Pharma Development America, Inc. ($1,626) |
All Payment Transactions
94 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | In-kind items and services | $385.81 | General |
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | In-kind items and services | $225.94 | General |
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | In-kind items and services | $225.94 | General |
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | In-kind items and services | $155.86 | General |
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $140.71 | General |
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $75.00 | General |
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $75.00 | General |
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $70.00 | General |
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $70.00 | General |
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | In-kind items and services | $64.00 | General |
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | In-kind items and services | $40.66 | General |
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $27.73 | General |
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $27.73 | General |
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $27.73 | General |
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $27.73 | General |
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | In-kind items and services | $16.42 | General |
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | In-kind items and services | $16.42 | General |
| 04/28/2023 | Eli Lilly and Company | — | — | In-kind items and services | $98.80 | Research |
| Study: RANDOMIZED PLACEBO CONTROLLED PHASE 2 CLINICAL TRIAL TO EVALUATE LY3556050 FOR THE TREATMENT OF OSTEOARTHRITIS PAIN | ||||||
| 06/22/2022 | Eli Lilly and Company | — | — | In-kind items and services | $85.00 | Research |
| Study: RANDOMIZED, PLACEBO CONTROLLED, PHASE 2 CLINICAL TRIAL TO EVALUATE LY3556050 FOR THE TREATMENT OF OSTEOARTHRITIS PAIN | ||||||
| 05/24/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/12/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/06/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/30/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/29/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/11/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: ANTI-INFECTIVE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| GBR830-204 | Ichnos Sciences Inc. | $907.37 | 12 |
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STUDY COMPARING THE EFFICACY AND SAFETY OF TIRZEPATIDE VERSUS PLACEBO IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH) | Eli Lilly and Company | $585.00 | 2 |
| RANDOMIZED, PLACEBO CONTROLLED, PHASE 2 CLINICAL TRIAL TO EVALUATE LY3556050 FOR THE TREATMENT OF OSTEOARTHRITIS PAIN | Eli Lilly and Company | $172.00 | 2 |
| RANDOMIZED PLACEBO CONTROLLED PHASE 2 CLINICAL TRIAL TO EVALUATE LY3556050 FOR THE TREATMENT OF OSTEOARTHRITIS PAIN | Eli Lilly and Company | $98.80 | 1 |
| Chronic Peripheral Polyneuropathy Randomized Trial | Nevro Corp. | $19.95 | 1 |
About Dr. Judith White, MD
Dr. Judith White, MD is a Internal Medicine healthcare provider based in Kingsport, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1316940018.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Judith White, MD has received a total of $9,299 in payments from pharmaceutical and medical device companies, with $1,673 received in 2024. These payments were reported across 94 transactions from 7 companies. The most common payment nature is "Travel and Lodging" ($3,706).
Ad
Practice Information
- Specialty Internal Medicine
- Location Kingsport, TN
- Active Since 05/27/2005
- Last Updated 09/24/2009
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1316940018
Products in Payments
- Omnia (Device) $2,100
- Senza Spinal Cord Stimulation System (Device) $1,522
- GBR830-204 (Drug) $907.37
- DALVANCE (Drug) $115.59
- XARELTO (Drug) $13.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Kingsport
Dr. David Metzger, M.d, M.D
Internal Medicine — Payments: $836,177
Internal Medicine $836,177
Dr. David Morin, Md, MD
Internal Medicine — Payments: $58,905
Internal Medicine $58,905
Dr. Shaun Colburn, M.d, M.D
Internal Medicine — Payments: $33,036
Internal Medicine $33,036
Sam Sadeghi, Md, MD
Internal Medicine — Payments: $18,226
Internal Medicine $18,226
William Steptoe, Md, MD
Internal Medicine — Payments: $12,522
Internal Medicine $12,522
Marc Mayhew, Md, MD
Internal Medicine — Payments: $8,910
Internal Medicine $8,910